NSAID-induced enteropathy: the current state of the problem

NSAID-induced enteropathy: the current state of the problem

The review analyzes the main etiological and pathogenetic mechanisms of the development of NSAID-enteropathy. Particular attention is paid to the role of intestinal microbiota in the manifestation and progression of NSAID-enteropathy. The special role of probiotics in the prevention and treatment of...

Full description

Bibliographic Details
Main Authors:	A A Svistunov, M A Osadchuk, N V Kireeva, A A Hudarova, E E Achkasov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2018-08-01
Series:	Терапевтический архив
Subjects:	nsaid-enteropathy acetylsalicylic acid antibiotics intestinal microbiota proton pump inhibitors linex® forte
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32810/pdf

Similar Items

NSAID enteropathy
by: E. N. Kareva
Published: (2020-02-01)

REBAMIPIDE: EFFECTIVE DRUG PREVENTION OF NSAID ENTEROPATHY IS POSSIBLE
by: E. V. Moroz, et al.
Published: (2016-12-01)

NSAID-induced damage to the gastrointestinal tract: new opportunities for the prevention of gastro- and enteropathies
by: V. N. Drozdov, et al.
Published: (2020-01-01)

Gut Microbiota in NSAID Enteropathy: New Insights From Inside
by: Xianglu Wang, et al.
Published: (2021-07-01)

Modern strategy of diagnostics and treatment of NSAID-induced enteropathy in elderly
by: Lipatova Т.Е., et al.
Published: (2015-03-01)

Modern opportunities for treatment and prevention of NSAID-induced enteropathies
by: I. A. Viktorova, et al.
Published: (2020-05-01)

The peculiarities of pathogenesis of NSAID-induced gastrointestinal injuries and current prevention strategies
by: Anatol Święcicki, et al.
Published: (2014-07-01)

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
by: Keszthelyi Daniel, et al.
Published: (2012-09-01)

COMPARING OF FAECAL CALPROTECTIN LEVELS IN PATIENTS WITH OSTEOARTHRITIS TAKING NSAID TREATMENT AND PATIENTS WITHOUT NSAIDS THERAPY
by: Olena Gubska, et al.
Published: (2020-03-01)

THE CLINICAL POTENTIAL OF LINEX FORTE® IN SYSTEMIC ANTIBIOTIC THERAPY
by: E. Y. Plotnikova, et al.
Published: (2017-12-01)

Current views on the role of probiotics in the prevention and treatment of different diseases: Focus on Linex
by: E A Ushkalova
Published: (2014-04-01)

NSAID–Gut Microbiota Interactions
by: Damian Maseda, et al.
Published: (2020-08-01)

Antiplatelet therapy with acetylsalicylic acid: Approaches to reducing the frequency of gastrointenstinal adverse reactions
by: E V Onuchina
Published: (2014-12-01)

Role of probiotics in the prevention and treatment of diarrhea of various genesis: Focus on Linex
by: E A Ushkalova
Published: (2014-03-01)

The improvement of treatment efficacy of gastropathy associated with the use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-negative patients with osteoarthritis
by: Antonenko Antonina V., et al.
Published: (2014-12-01)

The frequency and clinical and endoscopic features of mixed NSAIDs-induced gastrointestinal injuries
by: A. P. Balabantseva, et al.
Published: (2018-12-01)

Antibiotic-associated diarrhea in children: a current view of the problem
by: E. V. Kanner, et al.
Published: (2017-12-01)

CLINICAL AND PHARMACOLOGICAL CHARACTERISTICS OF THE USE OF REBAMIPIDE IN DISEASES OF THE GASTROINTESTINAL TRACT LITERATURE REVIEW
by: V. I. SIMANENKOV, et al.
Published: (2016-12-01)

Interobserver variation in the endoscopic diagnosis of gastroduodenal ulcer scars: implications for clinical management of NSAIDs users
by: Ishimura Norihisa, et al.
Published: (2011-10-01)

Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment
by: O M Drapkina, et al.
Published: (2016-12-01)

Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
by: Gwee KA, et al.
Published: (2018-02-01)

Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital
by: Lee HL, et al.
Published: (2016-11-01)

NSAID Enteropathy: A Review of the Disease Entity and Its Distinction from Crohn’s Enteropathy
by: Smita Esther Raju, et al.
Published: (2019-07-01)

Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice»
by: A. E. Karateev, et al.
Published: (2015-03-01)

Comparison of the impact of Helicobacter pylori eradication treatment with bismuth and non-bismuth quadruple regimens on the gut microbiota
by: S. Prast-Nielsen, et al.
Published: (2019-11-01)

Intestinal perforation complicating type II enteropathy-associated T-cell lymphoma
by: Fu-Chiang Yeh, et al.
Published: (2014-01-01)

Indomethacin-induced gastric ulceration in rats: Protective roles of Spondias mombin and Ficus exasperata
by: Saheed Sabiu, et al.
Published: (2015-01-01)

Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors
by: A E Karateev, et al.
Published: (2008-05-01)

Enteropathy induced by nonsteroid anti-inflammatory drugs
by: A E Karateev, et al.
Published: (2004-02-01)

Risk of upper gastrointestinal bleeding in a cohort of new users of low-dose ASA for secondary prevention of cardiovascular outcomes
by: Lucía Cea Soriano, et al.
Published: (2010-10-01)

Nonsteroidal anti‐inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after Helicobacter pylori eradication
by: Junya Arai, et al.
Published: (2021-07-01)

Rebamipide: New opportunities of gastroenteroprotection
by: V I Simanenkov, et al.
Published: (2015-12-01)

Prominent Indomethacin-Induced Enteropathy in Fcgriib <i>Defi-cient lupus</i> Mice: An Impact of Macrophage Responses and Immune Deposition in Gut
by: Thansita Bhunyakarnjanarat, et al.
Published: (2021-01-01)

Current approaches to the diagnosis and treatment for enteropathies
by: A I Parfenov
Published: (2014-02-01)

Naproxen: A universal analgesic with a minimal risk of cardiovascular events
by: A. E. Karateev
Published: (2016-06-01)

Congenital Tufting Enteropathy: Biology, Pathogenesis and Mechanisms
by: Barun Das, et al.
Published: (2021-12-01)

Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
by: Omran eAlsalahi, et al.
Published: (2015-01-01)

Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies
by: Romy M. Heilmann, et al.
Published: (2018-03-01)

New mutations of EpCAM gene for tufting enteropathy in Saudi Arabia
by: Shaden AlMahamed, et al.
Published: (2017-01-01)

The Modern Approaches to Prevention and Treatment of NSAID-Induced Gastropathy
by: S.M. Tkach
Published: (2013-11-01)